Taiwan’s GLAC Biotech Wins Two Innovation Awards for Probiotic Strain PL-02

Taipei, Taiwan – GLAC Biotech’s flagship probiotic strain, Lactobacillus plantarum PL-02, has received two awards at the 7th iSEE Global Innovation Awards, recognizing its advancements in both brain health and sports nutrition.

The probiotic, originally derived from the microbiome of an Olympic gold medalist, demonstrated exceptional results in studies focusing on energy metabolism, physical performance, and the gut-brain connection. Two ingredients developed from PL-02 were honored: PRONULIFE® IntBrain, designed to support cognitive function and emotional balance, and PRONULIFE® Effenergy, formulated to enhance athletic endurance and recovery. This recognition highlights the growing field of gut microbiome research and its impact on overall health.

The iSEE Global Innovation Awards are considered a prestigious honor within the health industry, often referred to as the “Oscars of the Health Industry,” and celebrate products with strong scientific backing. “PL-02 is more than a probiotic strain — it embodies the spirit of scientific excellence and human performance,” said a GLAC Biotech representative. “This recognition affirms our long-term commitment to clinical validation and global collaboration in functional probiotics.” The company’s success also elevates Taiwan’s position as a leader in biotech innovation, potentially attracting further investment in the sector.

GLAC Biotech will showcase its research at the Natural Extracts & Health Ingredients Exhibition (FIC-Health 2025) and the National Food Additives and Ingredients Exhibition from November 26–28, including a seminar on November 27 titled “Unlocking the Mind-Body Frontier — PL-02 Probiotic, a New Choice for Cognitive and Athletic Performance.” The company plans to continue expanding research into PL-02’s applications and forging global partnerships to bring its innovations to market, as detailed on their company website.